Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-11-14

FDA Approved: FASENRA — Original Application (AstraZeneca Pharmaceuticals LP)

View source ↗

Summary

The FDA granted original approval to FASENRA (benralizumab) from AstraZeneca as a treatment for adults with severe eosinophilic asthma. This establishes benrali…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FASENRA (BENRALIZUMAB)

Snippet

ORIG AP for FASENRA (BENRALIZUMAB)